Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Healthcare Sector Analysis

UpdatedJun 18, 2025
DataAggregated Company Financials
Companies35
  • 7D-2.9%
  • 3M-6.6%
  • 1Y4.4%
  • YTD2.9%

Over the last 7 days, the Healthcare industry has dropped 1.7%, driven by a pullback from Roche Holding of 3.0%. Meanwhile, Dottikon ES Holding actually outperformed within the industry, gaining 6.3% in the last week. This takes the industry's 12 month performance to a gain of 5.5%. Looking forward, earnings are forecast to grow by 14% annually.

Sector Valuation and Performance

Has the Swiss Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 18 Jun 2025CHF 582.8bCHF 151.3bCHF 22.5b30.5x25.9x3.9x
Fri, 16 May 2025CHF 567.7bCHF 152.6bCHF 22.7b32.4x25x3.7x
Sun, 13 Apr 2025CHF 522.5bCHF 149.8bCHF 21.7b25.8x24x3.5x
Tue, 11 Mar 2025CHF 632.6bCHF 154.7bCHF 22.4b27x28.2x4.1x
Thu, 06 Feb 2025CHF 623.1bCHF 155.6bCHF 22.3b30.4x27.9x4x
Sat, 04 Jan 2025CHF 571.1bCHF 153.0bCHF 24.6b28.4x23.2x3.7x
Mon, 02 Dec 2024CHF 579.6bCHF 150.8bCHF 24.2b29.2x24x3.8x
Wed, 30 Oct 2024CHF 608.5bCHF 149.6bCHF 24.0b30.3x25.3x4.1x
Fri, 27 Sep 2024CHF 608.8bCHF 147.1bCHF 22.3b32.3x27.3x4.1x
Sun, 25 Aug 2024CHF 625.6bCHF 147.2bCHF 22.3b32.9x28.1x4.3x
Tue, 23 Jul 2024CHF 602.9bCHF 149.4bCHF 23.5b34.6x25.6x4x
Thu, 20 Jun 2024CHF 570.2bCHF 148.0bCHF 22.6b35.4x25.2x3.9x
Sat, 18 May 2024CHF 565.7bCHF 146.0bCHF 22.9b33.7x24.7x3.9x
Mon, 15 Apr 2024CHF 546.4bCHF 145.2bCHF 22.4b35.2x24.4x3.8x
Wed, 13 Mar 2024CHF 538.0bCHF 142.8bCHF 22.5b36.1x23.9x3.8x
Fri, 09 Feb 2024CHF 511.8bCHF 142.3bCHF 22.3b32.5x23x3.6x
Sun, 07 Jan 2024CHF 536.4bCHF 151.2bCHF 21.8b26.7x24.6x3.5x
Tue, 05 Dec 2023CHF 517.7bCHF 152.9bCHF 22.0b25.4x23.6x3.4x
Thu, 02 Nov 2023CHF 496.5bCHF 155.5bCHF 22.2b23.6x22.3x3.2x
Sat, 30 Sep 2023CHF 535.8bCHF 146.1bCHF 21.2b32.2x25.2x3.7x
Mon, 28 Aug 2023CHF 544.2bCHF 144.2bCHF 21.1b29.3x25.8x3.8x
Wed, 26 Jul 2023CHF 560.6bCHF 146.0bCHF 22.4b36.1x25x3.8x
Fri, 23 Jun 2023CHF 563.3bCHF 147.2bCHF 22.2b34.3x25.3x3.8x
Sun, 21 May 2023CHF 584.3bCHF 147.4bCHF 22.2b35.3x26.3x4x
Tue, 18 Apr 2023CHF 582.6bCHF 146.9bCHF 22.4b34.1x26x4x
Thu, 16 Mar 2023CHF 517.0bCHF 148.7bCHF 22.6b27.7x22.9x3.5x
Sat, 11 Feb 2023CHF 546.2bCHF 148.0bCHF 22.7b32.5x24x3.7x
Mon, 09 Jan 2023CHF 566.7bCHF 148.7bCHF 38.1b30.5x14.9x3.8x
Wed, 07 Dec 2022CHF 576.3bCHF 149.4bCHF 38.4b30.9x15x3.9x
Fri, 04 Nov 2022CHF 585.6bCHF 152.7bCHF 39.6b29x14.8x3.8x
Sun, 02 Oct 2022CHF 563.4bCHF 152.1bCHF 40.3b27.3x14x3.7x
Tue, 30 Aug 2022CHF 577.3bCHF 151.2bCHF 40.0b25.3x14.4x3.8x
Thu, 28 Jul 2022CHF 604.2bCHF 150.2bCHF 39.8b33x15.2x4x
Sat, 25 Jun 2022CHF 582.1bCHF 148.3bCHF 40.2b30x14.5x3.9x
Price to Earnings Ratio

14.5x


Total Market Cap: CHF 582.1bTotal Earnings: CHF 40.2bTotal Revenue: CHF 148.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Healthcare Sector Price to Earnings3Y Average 23x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 26.1x which is higher than its 3-year average PE of 23.0x.
  • The industry is trading close to its 3-year average PS ratio of 3.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 18% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare sector?

CH Market-2.51%
Healthcare-2.85%
Healthcare Services0.33%
Healthtech-1.08%
Pharma-2.59%
Life Sciences-3.26%
Medical Equipment-4.24%
Biotech-4.95%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 44.8x.
    • Analysts are expecting annual earnings growth of 19.5%, which is lower than the prior year's growth of 24.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 35% over the next 5 years.
  • This is better than its past earnings decline of 79% per year.
  • In contrast, the Biotech industry is expected to see its earnings decline by 10% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DESN Dottikon ES HoldingCHF 296.506.3%
+CHF 241.8m		15.4%PE38.8x
MEDX medmixCHF 11.367.2%
+CHF 31.0m		-23.9%PS1x
AEVS Aevis VictoriaCHF 13.501.1%
+CHF 12.6m		-15.9%PS1.3x
GALE GalenicaCHF 85.800.2%
+CHF 7.5m		16.7%PE23.4x
XLS Xlife SciencesCHF 20.202.3%
+CHF 2.6m		-38.2%PE3.4x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ROG

CHF 261.60

Roche Holding

7D

-3.0%

1Y

5.5%

NOVN

CHF 95.57

Novartis

7D

-2.0%

1Y

2.6%

Novartis AG (VTX:NOVN) Doing What It Can To Lift Shares

Jun 18
Novartis AG (VTX:NOVN) Doing What It Can To Lift Shares

DESN

CHF 296.50

Dottikon ES Holding

7D

6.3%

1Y

15.4%

Here's Why Dottikon ES Holding (VTX:DESN) Has Caught The Eye Of Investors

Jun 18
Here's Why Dottikon ES Holding (VTX:DESN) Has Caught The Eye Of Investors

GALD

CHF 108.10

Galderma Group

7D

-4.3%

1Y

44.0%

SOON

CHF 245.50

Sonova Holding

7D

-5.1%

1Y

-9.5%

Sonova Holding (VTX:SOON) Has Announced That It Will Be Increasing Its Dividend To CHF4.40

Jun 12
Sonova Holding (VTX:SOON) Has Announced That It Will Be Increasing Its Dividend To CHF4.40

STMN

CHF 104.35

Straumann Holding

7D

-5.4%

1Y

-2.7%

Straumann Holding AG's (VTX:STMN) Intrinsic Value Is Potentially 21% Below Its Share Price

Jun 11
Straumann Holding AG's (VTX:STMN) Intrinsic Value Is Potentially 21% Below Its Share Price

RLF

CHF 2.22

Relief Therapeutics Holding

7D

2.1%

1Y

97.8%

BIOV

CHF 35.80

BioVersys

7D

1.1%

1Y

n/a

XLS

CHF 20.20

Xlife Sciences

7D

2.3%

1Y

-38.2%

SDZ

CHF 42.40

Sandoz Group

7D

-2.4%

1Y

31.6%

LONN

CHF 559.80

Lonza Group

7D

-2.9%

1Y

17.4%

Lonza Group AG (VTX:LONN) Not Flying Under The Radar

May 31
Lonza Group AG (VTX:LONN) Not Flying Under The Radar

ALC

CHF 70.06

Alcon

7D

-4.1%

1Y

-11.0%

GALE

CHF 85.80

Galenica

7D

0.2%

1Y

16.7%

Galenica AG's (VTX:GALE) Business Is Yet to Catch Up With Its Share Price

May 29
Galenica AG's (VTX:GALE) Business Is Yet to Catch Up With Its Share Price

METN

CHF 1,050.00

Metall Zug

7D

0.5%

1Y

-16.7%

AEVS

CHF 13.50

Aevis Victoria

7D

1.1%

1Y

-15.9%

MEDX

CHF 11.36

medmix

7D

7.2%

1Y

-23.9%